Hypoglycemia in Adults - Emergency Medicine Reports - May 20, 2012

Target Audience:

This CME activity is intended for emergency physicians and family physicians.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.3 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is approved by the American College of Emergency Physicians for 2.25 hours of ACEP Category 1 credits.
Emergency Medicine Reports has been reviewed and is acceptable for up to 1.5 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 01/01/12. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.


J. Stephan Stapczynski, MD
Emergency Medicine Department
Maricopa Medical Center
Phoenix, Arizona

Sandra M. Schneider, MD
Professor, Department of Emergency Medicine
University of Rochester School of Medicine
Rochester, New York

Gregory R. Wise, MD, FACP
Associate Professor of Medicine
Wright State University
Dayton, OH;
Vice President, Medical Affairs
Kettering Medical Center
Kettering, OH

CME Question Reviewer
Roger Farel, MD
Newport Beach, CA

Executive Editors
Shelley Mark

Leslie Coplin

Managing Editors
Leslie Hamlin

Neill Kimball

Cara O'Shaughnessey, DO
Diabetes Fellow
Ohio University Heritage College of Osteopathic Medicine
O'Bleness Health System, Athens, OH

Jay H. Shubrook, Jr., DO, FACOFP, FAAFP
Associate Professor of Family Medicine and Director of Diabetes Fellowship
Ohio University Heritage College of Osteopathic Medicine, Athens, OH

Peer Reviewer
Ademola Adewale, MD, FAAEM
Director of Research and Medical Simulation
Assistant Program Director
Florida Hospital Emergency Medicine Residency, Orlando, FL


  • Hypoglycemia in Adults


  • Recognize or increase index of suspicion for specific conditions
  • State the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Apply state-of-the-art diagnostic and therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed.
  • Discuss the differential diagnosis of the entity discussed.
  • Explain both likely and rare complications that may occur.

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Roger Farel, MD (CME question reviewer) owns stock in Johnson& Johnson. J. Stephan Stapczynski, MD (editor) owns stock in Bristol Myers Squibb. Sandra M. Schneider, MD (editor), Cara O'Shaughnessey, DO (author), Jay H. Shubrook, Jr., DO, FACOFP, FAAFP (author), Ademola Adewale, MD, FAAEM (peer reviewer), Gregory R. Wise, MD, FACP (editor), Leslie Coplin (executive editor), and Neill Kimball (managing editor) report no financial relationships relevant to this field of study, Shelley Mark (executive editor), and Leslie Hamlin (managing editor) report no financial relationships with companies related to the field of study covered by this CME activity.

Copyright 2012 AHC Media LLC. All rights reserved.